Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered
Human content, AI powered search.

Latest Stories

Search

Human content, AI powered search.

Search Results for DISPARITY IN HEALTHCARE ACCESS

Spotlight on midlife chronic pain on World Menopause Day
News

Spotlight on midlife chronic pain on World Menopause Day

With up to 71% of perimenopausal women experiencing pain unreflected in standard scans, experts call for gender-sensitive, multidisciplinary care

Reset Health, Pharmacy2U join hands to launch Averly Health
News

Reset Health, Pharmacy2U join hands to launch Averly Health

The partnership aims for provide nationwide integrated cardiometabolic care

Government partnership with Breast Cancer Now
Women’s Health

Government partnership with Breast Cancer Now

MPs call for sustainable funding to help pharmacies keep their doors open

MPs call for sustainable funding to help pharmacies keep their doors open

A Westminster Hall debate focused on Government funding for community pharmacies and the pressures affecting pharmacy businesses across England

Many NHS trusts continue to rely on pen and paper for clinical notes
News

Many NHS trusts continue to rely on pen and paper for clinical notes

Despite all hospital trusts having an electronic patient record in place, 79% (145) reported that they still relied on pen and paper to some extent for documenting clinical notes

NHS missing up to 95% of breast cancer risk among young women
News

NHS missing up to 95% of breast cancer risk among young women

Breast cancer screening relies heavily on family history while ignoring lifestyle and genetic factors

Pharmacy leaders call for business rate relief
News

Pharmacy leaders call for business rate relief

CPE, NPA and IPCN question why community pharmacies have not been considered in support for high streets

Generic semaglutide fuels UK grey market, expert warns
News

Unregulated entry of generic semaglutides to spur UK's grey market: Expert

Dr Sophie Dix points out that though generic drugs are manufactured legally, they will enter the UK through unregulated channels and lack clinical oversight